PulseAugur
EN
LIVE 18:23:04

Montana advances 'right to try' law for experimental drugs

By PulseAugur Editorial · [1 sources] ·

Montana is advancing a unique plan to become a hub for experimental medical treatments, allowing biotech companies to sell unapproved drugs to consumers. The state has finalized rules for its expanded "right to try" law, which theoretically permits access to any individual who can pay and provides informed consent, not just those with terminal illnesses. This initiative, driven by longevity enthusiasts, has raised concerns among some experts about the potential risks of selling unproven treatments without FDA oversight. AI

RANK_REASON Policy change by a US state government enabling sale of unapproved drugs. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on MIT Technology Review →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Montana advances 'right to try' law for experimental drugs

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Policy change by a US state government enabling sale of unapproved drugs. [lever_c_demoted from significant: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, product
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
58 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. MIT Technology Review TIER_1 English(EN) · Jessica Hamzelou ·

    Montana’s plan to become an experimental medical hub just pushed forward

    As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board…

RELATED ENTITIES

RELATED TOPICS